Biogen to Acquire Human Immunology Biosciences for Up to $1.8 Billion
- May 24, 2024
Biogen Inc. is looking to boost its immunology portfolio with a deal to acquire Human Immunology Biosciences (Hi-Bio) for up to $1.8 billion, the companies announced May 22.
ARTICLE TAGS
You must be logged in to access this content.